The 0.2-μg/day Fluocinolone Acetonide Intravitreal Implant in Chronic Noninfectious Posterior Uveitis: A 3-year Randomized Trial in India

OBJECTIVE: To examine the long-term efficacy and safety of the intravitreal 0.2-μg/day fluocinolone acetonide implant (FAi) to treat noninfectious uveitis (NIU) of the posterior segment (PS). DESIGN: Three-year, phase III, multicenter, randomized, double-masked, controlled, prospective study (clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Biswas, Jyotirmay, Tyagi, Mudit, Agarwal, Manisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630780/
https://www.ncbi.nlm.nih.gov/pubmed/38027419
http://dx.doi.org/10.1016/j.xops.2023.100403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630780/
https://www.ncbi.nlm.nih.gov/pubmed/38027419
http://dx.doi.org/10.1016/j.xops.2023.100403

Ejemplares similares